Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
31 Results Found
Door County Medical Center | Wisconsin
Door County Medical Center (DCMC) has been serving the people of Door and Kewaunee counties in Wisconsin for more than 80 years.
Our Lady of the Lake Health | Louisiana
Our Lady of the Lake Health, a part of the Franciscan Missionaries of Our Lady Health System, has been a leading provider of high-quality care in the Baton Rouge community for more than 100 years.
Johnson County Hospital | Nebraska
Johnson County Hospital is an 18-bed critical access hospital based in Tecumseh, Nebraska.
Grand Junction Community Hospital | Colorado
Community Hospital is an
independent, nonprofit acute
care hospital that’s been
operating in Grand Junction, Colo., since 1946.
340B Benefits Patients and Communities: Examples from the Frontlines
The 340B Drug Pricing Program helps ensure access to care for patients and communities most in need. A bipartisan effort by Congress in 1992 designed the program to protect hospitals from rising drug costs — a dynamic that continues to present major challenges today.
Valleywise Health | Arizona
Valleywise Health, with its 340B Program savings, reinvests back into programs that directly benefit patients and the larger community, providing access to high-quality care for all.
Monument Health | South Dakota
Monument Health is the largest health care provider in western South Dakota. It is an integral part of the local community, providing a wide array of vital services including behavioral health, oncology and dialysis care.
340B Hospital Community Benefit Analysis - September 2025
In 2022, tax-exempt hospitals participating in the 340B Drug Pricing Program provided nearly $100 billion in total benefits to their communities, according to a new AHA report.
AHA Report: The 340B Drug Pricing Program
The 340B Drug Pricing Program allows hospitals caring for large numbers of underserved patients to stretch scarce federal resources and provide more comprehensive care by requiring drug companies to offer discounted prices on certain outpatient drugs.
More Drug Company Oversight Needed to Maintain Compliance with 340B Program Rules
Not only are 340B Drug Pricing Program hospitals subject to disproportionately greater oversight by the federal government, they outperform drug companies in terms of program compliance to a substantial degree. These discrepancies underscore the need for increased federal oversight of drug manufacturers, as well as rejection of their unlawful approach to convert the discount program to a rebate model.